AC Followed by Docetaxel/Trastuzumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cyclophosphamide and doxorubicin followed by docetaxel and trastuzumab, used as a neoadjuvant or adjuvant treatment for HER-2/neu-positive breast cancer.

**Synonyms:** - AC Followed by Docetaxel + Trastuzumab - AC-Docetaxel + Trastuzumab - AC-T Plus Trastuzumab - AC-TH - AC-TH (Docetaxel) - AC-TH (Docetaxel) (trastuzumab-anns) - AC-TH (Docetaxel) (trastuzumab-dkst) - AC-TH (Docetaxel) (trastuzumab-dttb) - AC-TH (Docetaxel) (trastuzumab-herw) - AC-TH (Docetaxel) (trastuzumab-pkrb) - AC-TH (Docetaxel) (trastuzumab-qyyp) - AC-TH (Docetaxel) (trastuzumab-strf) - AC-TH (Docetaxel) (trastuzumab-zerc) - AC-Taxotere/Herceptin - Doxorubicin/Cyclophosphamide Followed by Docetaxel + Trastuzumab - Doxorubicin/Cyclophosphamide Followed by Docetaxel/Trastuzumab